[Linezolid therapy for infectious endocarditis]

Ugeskr Laeger. 2010 Apr 19;172(16):1215-6.
[Article in Danish]

Abstract

In Denmark enterococci causes 15 to 20% of all endocarditis (IE) cases. The development of multi-resistant bacterial strains has increased the need for new antibiotics. Linezolid is an alternative to conventional treatment of infections with gram positive cocci. In this case report linezolid was used to treat IE in a patient, who was allergic to penicillin and where conventional treatment caused development of acute renal failure. No side effects were observed and the patient responded well to the treatment.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Acetamides / administration & dosage
  • Acetamides / therapeutic use*
  • Aged, 80 and over
  • Anti-Bacterial Agents / adverse effects
  • Anti-Bacterial Agents / therapeutic use
  • Anti-Infective Agents / administration & dosage
  • Anti-Infective Agents / therapeutic use*
  • Drug Resistance, Multiple, Bacterial
  • Endocarditis, Bacterial / drug therapy*
  • Endocarditis, Bacterial / microbiology
  • Enterococcus faecalis / drug effects
  • Enterococcus faecalis / isolation & purification
  • Female
  • Humans
  • Linezolid
  • Oxazolidinones / administration & dosage
  • Oxazolidinones / therapeutic use*
  • Treatment Outcome

Substances

  • Acetamides
  • Anti-Bacterial Agents
  • Anti-Infective Agents
  • Oxazolidinones
  • Linezolid